Purchase Order 75N91025P00434

Award Date 7/8/25
Potential Completion Date 8/8/25
Potential Value $15K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Newton, MA 02459, USA
Solicitation Procedures
Only One Source
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a firm fixed-price purchase order contract awarded by the National Cancer Institute (NCI), a civilian agency within the Department of Health and Human Services, to Intera Oncology Inc., a for-profit medical device and laboratory supply company located in Newton, Massachusetts. The contract is for the delivery of INFUSION PUMPs with a ceiling value of $14,790.00 and a period of performance through June 18, 2025. The contract was awarded on May 19, 2025 and does not have a set-aside...
This is a firm fixed-price purchase order contract awarded by the National Cancer Institute (NCI), a component of the National Institutes of Health within the U.S. Department of Health and Human Services, to Intera Oncology Inc., a for-profit medical device and laboratory supply company located in Newton, Massachusetts. The contract, valued at $14,790, is for the delivery of Intera3000 infusion pumps to support the NCI's cancer research and treatment programs. The contract does not have a...
This firm fixed price purchase order was awarded by the National Cancer Institute (NCI), a civilian agency within the Department of Health and Human Services, to Intera Oncology Inc. on October 18, 2024. The contract has a ceiling value of $14,390.00 and a completion date of December 17, 2024. Intera Oncology Inc. is a for-profit medical device and laboratory supply company that specializes in providing infusion pumps, laboratory equipment, and general laboratory supplies to support the NCI's...
This is a firm fixed price purchase order awarded by the National Cancer Institute (NCI), a civilian agency within the Department of Health and Human Services, to Intera Oncology Inc., a for-profit medical device and laboratory supply company. The contract, valued at $14,390.00, is for the delivery of Intera3000 infusion pumps and other laboratory equipment and supplies to support NCI's cancer research and treatment programs. The contract has no set-aside designation, indicating that Intera...
This is a firm fixed price purchase order contract awarded by the National Cancer Institute (NCI), a civilian agency within the Department of Health and Human Services, to Intera Oncology Inc., a for-profit medical device and laboratory supply company. The contract is for the delivery of Intera3000 infusion pumps and various laboratory equipment and supplies to support the NCI's cancer research and treatment programs. The contract has a ceiling value of $14,390.00 and a period of performance...
This is a firm fixed price purchase order awarded by the National Cancer Institute (NCI), a civilian agency within the Department of Health and Human Services, to Intera Oncology Inc., a for-profit medical device and laboratory supply company. The contract, valued at $14,390.00, is for the delivery of laboratory supplies including infusion pumps and other equipment to support NCI's cancer research and treatment programs. Intera Oncology Inc. has an established relationship with NCI, having...
The Department of Health and Human Services' National Institutes of Health National Cancer Institute (HHS-NIH-NCI) awarded a firm fixed price purchase order contract to Intera Oncology Inc., a for-profit organization, to provide infusion pumps and other laboratory equipment and supplies in support of cancer research efforts. The contract has a potential value of $14,390.00 and a completion date of May 20, 2024. No set-aside designation was used for this award. Intera Oncology Inc. has previously...
This is a $14,390.00 firm fixed price purchase order awarded by the Department of Health and Human Services' National Institutes of Health National Cancer Institute (HHS-NIH-NCI) to Intera Oncology Inc., a for-profit organization, to provide laboratory supplies in support of cancer research efforts. The contract does not have a set-aside designation and was awarded directly to Intera Oncology Inc. as the prime contractor, with no mention of subcontractors. The purchase order includes the...
The U.S. Department of Health and Human Services' National Cancer Institute (HHS-NIH-NCI) awarded a $14,390.00 firm fixed price purchase order contract to Intera Oncology Inc., a for-profit medical device and laboratory supply company. The contract is for the delivery of Intera3000 infusion pumps and other general laboratory equipment to support the NCI's cancer research programs, including clinical trials and standard care therapy for cancer patients. This contract does not have a set-aside...
This is a federal contract award for $14,390.00 to Intera Oncology Inc., a for-profit medical device and laboratory supply company. The contract, awarded by the National Cancer Institute (NCI), a civilian agency within the Department of Health and Human Services, is for the delivery of laboratory supplies, including the company's Intera3000 infusion pumps and other medical devices. The contract is a firm fixed-price purchase order with an ultimate completion date of August 25, 2024. This award...

This is a firm fixed-price purchase order contract awarded by the National Cancer Institute (NCI), a civilian agency within the Department of Health and Human Services, to Intera Oncology Inc., a for-profit medical device and laboratory supply company based in Newton, Massachusetts. The contract is for the purchase of Intera 3000 Hepatic Artery Infusion Pumps, which are implantable devices used to administer medication directly to the hepatic artery of cancer patients as a standard of care therapy. The contract has a ceiling value of $14,790.00 and a period of performance ending on August 8, 2025. There was no set-aside designation for this contract, indicating open market competition. The award supports the NCI's research programs, clinical trials, and patient care initiatives related to cancer treatment.

Generated 7/8/25, 2:39 PM